






































deteriorates	more	 rapidly	 with	 age	 among	men	 and	women	with	 lower	 socioeconomic	 status	
(SES)	 than	among	 those	with	higher	 SES.	 The	biological	 processes	 underlying	 these	differences	
are	 best	 understood	 by	 adopting	 a	 life	 course	 approach.	 In	 this	 paper	 we	 introduce	 the	 pan-
European	 LIFEPATH	 project	 which	 uses	 multiple	 cohorts	 –	 including	 biomarker	 data	 –	 to	
investigate	ageing	as	a	phenomenon	with	two	broad	stages	across	life:	build-up	and	decline.	The	
‘build-up’	 stage,	 from	 conception	 and	 early	 intra-uterine	 life	 to	 late	 adolescence	 or	 early	
twenties,	is	characterised	by	rapid	successions	of	developmentally	and	socially	sensitive	periods.	
The	 second	 stage,	 starting	 in	 early	 adulthood,	 is	 a	 period	 of	 'decline'	 from	maximum	attained	
health	to	loss	of	function,	overt	disease	and	death.		
LIFEPATH	adopts	a	study	design	that	integrates	social	science	and	public	health	approaches	with	
biology	 (including	 molecular	 epidemiology),	 using	 well-characterised	 population	 cohorts	 and	
omics	 measurements	 (particularly	 epigenomics).	 LIFEPATH	 includes	 information	 and	 biological	
samples	 from	 17	 cohorts,	 including	 several	 with	 extensive	 phenotyping	 and	 repeat	 biological	
samples,	and	a	very	 large	cohort	(1	million	 individuals)	without	biological	samples	(WHIP,	from	
Italy).	 The	 countries	 that	 are	 covered	 by	 the	 cohorts	 are	 France,	 Italy,	 Portugal,	 Ireland,	 UK,	
Finland,	 Switzerland	 and	 Australia.	 These	 cohorts	 are	 only	 a	 small	 proportion	 of	 all	 cohorts	
available	 in	 Europe,	 but	 we	 have	 chosen	 them	 for	 the	 combination	 of	 good	 measures	 of	
socioeconomic	 status,	 risk	 factors	 for	 non-communicable	 diseases	 (NCDs)	 and	 biomarkers	
already	measured	 (or	availability	of	blood	samples	 for	 further	 testing).	The	majority	of	cohorts	
include	 ‘hard’	 outcomes	 (diabetes,	 cancer,	 Cardiovascular	 Disease	 (CVD),	 total	mortality),	 and	
the	 extensively	 phenotyped	 cohorts	 also	 include	 several	 measurements	 of	 the	 functional	
components	 of	 healthy	 ageing,	 including	 frailty,	 impaired	 vision,	 cognitive	 function,	 renal	 and	
brain	 function,	 osteoporosis,	 sleep	 disturbances	 and	 mental	 health.	 All	 age	 groups	 are	
represented	with	two	birth	cohorts,	one	cohort	of	adolescents	and	several	cohorts	encompassing	












up	data	 to	obtain	mortality	 by	 socioeconomic	 status;	 2.	 cohorts	with	 intense	phenotyping	and	
repeat	 biological	 samples;	 3.	 large	 cohorts	with	 biological	 samples.	With	 these	 objectives	 and	
methodologies,	 LIFEPATH	 seeks	 to	 provide	 updated,	 relevant	 and	 innovative	 evidence	 to	
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Aims	in	brief	of	LIFEPATH	
LIFEPATH	 is	 a	 large	 consortium	 of	 cohort	 studies	
with	the	following	aims:	
I. To	demonstrate	 that	healthy	ageing	 is	highly	
variable	 in	 society,	 due	 to	 multiple	
environmental,	 behavioural	 and	 social	
circumstances	 that	 affect	 individual	 life	
trajectories.		
II. To	 improve	 the	 understanding	 of	 the
mechanisms	 through	 which	 healthy	 ageing
pathways	diverge	by	social	circumstances,	by
investigating	 life	 course	 biological	 pathways
using	biomarkers	and	omic	technologies.
III. To	 provide	 evidence	 on	 the	 reversibility	 of
the	poorer	ageing	trajectories	experienced	by
individuals	 exposed	 to	 the	 strongest
adversities;	 and	 to	 analyse	 the	 health
consequences	 of	 the	 current	 economic
recession	in	Europe	(i.e.	changes	in	social	and
economic	circumstances).
IV. To	provide	updated,	 relevant	 and	 innovative
evidence	to	inform	future	policies.





of	 life	 and	 life	 expectancy	 observed	 between	
individuals	from	different	socioeconomic	groups	is	a	
major	 societal	 challenge	 that	 Europe	 is	 currently	
facing.	 Healthy	 ageing	 is	 an	 achievable	 goal	 in	
society	as	it	is	already	experienced	by	individuals	in	
the	highest	 socioeconomic	groups.	 Individuals	with	
high	 socioeconomic	 status	 (SES)	 experience	 much	
better	health	and	healthier	ageing	than	groups	with	
low	 SES.	 Healthy	 ageing	 is	 also	 strongly	 related	 to	
cumulative	 exposure	 to	 harmful	 events	 during	 the	
life	 course,	 and	 particularly	 in	 sensitive	 or	 critical	
periods.	There	is	strong	evidence	that	(a)	the	risk	of	
disease	 is	 influenced	 by	 early	 exposures,	 including	
in	 utero	 exposures;	 (b)	 the	 life	 course	 is	
characterised	 by	 critical	 periods	 (during	 which	









					Socioeconomic	 differences	 in	 health	 are	 striking	
and	 are	 seen	 in	 all	 European	 countries	
(Mackenbach	 et	 al.,	 2008).	 Physical	 health	
deteriorates	 more	 rapidly	 with	 age	 for	 men	 and	
women	 from	 lower	 socioeconomic	 groups	 than	




					This	 creates	 a	 progressively	 increasing	 health	
differential	 between	 social	 groups	 such	 that	 the	
average	 physical	 health	 of	 a	 70	 year	 old	 man	 or	
woman	with	high	SES	 is	 similar	 to	 that	of	a	person	
with	 low	 SES	 (occupational	 grade)	 who	 is	 eight	
years	younger	(Chandola,	Ferrie,	Sacker	&	Marmot,	
2007).	 These	 differences,	 and	 the	 biological	
processes	 underlying	 them,	 cannot	 be	 understood	
without	 adopting	 a	 life	 course	 approach.	 In	 the	
project	 we	 describe	 below	 we	 use	 the	 revised	
Strachan-Sheikh	 (2004)	 model	 of	 life-course	
functioning	 (Blane,	 Kelly-Irving,	 d’Errico,	 Bartley	 &	
Montgomery,	 2013;	 Kuh,	 2007,	 2014;),	 to	 describe	
ageing	 over	 a	 lifetime.	 This	model	 presents	 ageing	
as	 a	phenomenon	with	 two	broad	 stages:	 build-up	
and	 decline.	 The	 ‘build-up’	 stage,	 from	 conception	
and	 early	 intra-uterine	 life	 to	 late	 adolescence	 or	
early	twenties,	is	characterised	by	rapid	successions	
of	 developmentally	 and	 socially	 sensitive	 periods.	
This	 stage	 strongly	 determines	 subsequent	 ageing	
trajectories	 as	 it	 influences	 the	maximum	 attained	
level	 of	 health.	 The	 second	 stage,	 starting	 in	 early	
adulthood,	 is	 a	 period	 of	 'decline'	 from	maximum	
attained	 health	 to	 loss	 of	 function,	 overt	 disease	
and	 death.	 Lifestyle	 and	 exposures	 during	 the	
second	 stage	 can	 influence	 the	 rate	 at	 which	
functioning	 is	 lost	 (Figure	 1-	 dashed	 line).	We	 are	
aware	 that	 this	 working	 scheme	 is	 a	 simplification	
and	does	not	incorporate	the	complex	relationships	
that	 underlie	 ageing	 processes,	 but	we	 use	 it	 as	 a	




					There	 is	much	evidence	 that	 low	SES	 across	 the	
life	 course	 is	 associated	 with	 poor	 ageing	
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trajectories	 and	 early	 death	 (Chetty	 et	 al,	 2016;	
House,	 Lantz	 &	 Herd,	 2005;	Mackenbach,	 J.	 et	 al.,	
2008;	Stringhini,	et	al.,	2010).	There	is	evidence	that	
the	 impact	 of	 SES	 on	 ageing	 is	 partly	mediated	 by	
risk	 factors	 for	 non-communicable	 diseases	 (NCD),	
but	this	 is	not	the	only	pathway.	Also,	the	features	
of	 low	 SES	 in	 high-income	 countries	 have	
dramatically	 changed	 over	 the	 last	 century.	 In	
Europe,	 low	 SES	 is	 often	 associated	 with	 food	
abundance	 (but	 of	 poor	 quality),	 lack	 of	 physical	
exercise,	 and	 psychosocial	 stress	 (including	 sleep	
deprivation	and	mental	problems)	 (Dugravot	et	al.,	
2010;	 Kivimäki	 et	 al.,	 2002;	 Kivimäki	 et	 al.,	 2012;	
Kivimäki	 et	 al.,	 2015;Stringhini	 et	 al.,	 2010;	
Stringhini	 et	 al.,	 2012).	 This	 adds	 to	 the	 traditional	
stressors,	 such	 as	 physical	 fatigue	 related	 to	
occupation	 and	 housework.	 Analyses	 in	 the	 Gazel	




					SES	 is	 linked	 to	 many	 determinants	 of	 health,	
including:	 1)	 access	 to	 and	 use	 of	medical	 care;	 2)	
access	 to	 health	 information;	 3)	 patterns	 of	
unhealthy	 behaviours	 (smoking,	 heavy	 drinking,	
unhealthy	 diet,	 physical	 inactivity,	 drug	 use);	 4)	
exposure	 to	 environmental	 and	 occupational	
hazards;	 5)	 exposure	 to	 stressful	 life	 events;	 6)	
access	 to	 resources	 mediating	 the	 physiological	
consequences	 of	 stress	 (social	 relationships	 and	
support	 and	 cultural	 capital);	 7)	 early	 life	 adverse	
experiences;	8)	age	and	time-related	susceptibilities	
(Abel,	2008;	James,	Nelson,	Ralph	&	Leather,	1997;	
Kelly-Irving,	 et	 al.,	 2011;	 Lantz,	 House,	 Mero	 &	
Williams,	 2005;	 Lynch,	 Kaplan	 &	 Shema,	 1997;	
Mitchell,	Blane	&	Bartley,	2002;	Siegrist	&	Marmot,	
2004;	 van	 Doorslaer,	 Masseria,	 Koolman	 &	 the	
OECD	 Health	 Equity	 research	 Group,	 2006).	 The	
Whitehall	 studies	 (part	 of	 LIFEPATH)	 have	 shown	
that	 the	SES	gradient	 in	unhealthy	ageing	and	CVD	
in	 particular	 is	 not	 completely	 explained	 by	
traditional	risk	factors,	even	when	they	are	reduced	
to	 the	 lowest	 levels	 for	 the	 whole	 population	
(Kivimäki	et	al.,	2008;	Marmot,	Shipley,	Hemingway,	
Head	&	Brunner,	2008).	 In	addition,	global	changes	
in	 the	 economy	 are	 accompanied	 by	 rising	 social	
inequalities.	 Instability	 of	 markets	 and	 lack	 of	




by	 the	 global	 scientific	 and	 policy	 community,	 as	
demonstrated	by	the	publication	of	an	 issue	of	the	
Science	 magazine	 devoted	 to	 socioeconomic	
differentials,	 their	projections,	 and	 their	 impact	on	
health	(Chin	&	Culotta,	2014;	Piketty	&	Saez,	2014).		
3. Role	of	behavioural	risk	factors
					Though	 epidemiology	 has	 extensively	
investigated	chemical,	physical	and	behavioural	risk	
factors	 (such	 as	 smoking,	 diet,	 alcohol,	 physical	
exercise,	 and	 occupational	 factors),	 these	 still	
explain	only	a	 fraction	of	 the	burden	of	NCD’s	and	
of	 common	 disabilities.	 For	 example,	 a	 large	
fraction	of	breast,	colon	and	prostate	cancers	is	not	
explained	by	known	 risk	 factors,	 and	 the	causes	of	
common	 conditions	 such	 as	 cognitive	 impairment	
are	 largely	 unknown.	 The	 United	 Nations	 25x25	
strategy	for	NCDs	(aiming	to	reduce	mortality	from	
NCDs	 by	 25%	 by	 the	 year	 2025)	 lists	
diabetes/obesity,	 alcohol,	 physical	 exercise,	
tobacco,	raised	blood	pressure	and	salt	as	the	main	
targets	 of	 preventive	 programmes.	 The	 strategy	 is	
limited	 by	 (a)	 referring	 exclusively	 to	 known	 risk	
factors,	 (b)	 excluding	 highly	 prevalent	 conditions	
that	 limit	 individual	 functioning,	 such	 as	 cognitive	
decline	 and	musculoskeletal	 disorders,	 and	 (c)	 not	
accounting	 for	 the	 social	 structure	 that	 underpins	
the	 distribution	 of	 known	 risk	 factors	 and	 the	
effectiveness	of	preventive	strategies	and	policies.		
					A	 considerable	 amount	 of	 evidence	 shows	 that	
socioeconomic	factors	are	as	important	as	lifestyle-
related	 risk	 factors,	 and	 chemical	 and	 physical	
agents,	in	determining	healthy	ageing	(House	et	al.,	
2005;	Kelly-Irving	et	al.,	2013;	Stringhini	et	al.,	2010;	
Stringhini	 et	 al.,	 2017)	 Low	 SES	 is	 one	 of	 the	
strongest	 predictors	 of	 healthy	 ageing	 in	 Europe,	
where,	on	average,	disability-free	life	expectancy	at	
age	65	 is	4.5	years	shorter	 in	the	 lowest	SES	group	
than	 in	 the	 highest	 group	 (Majer,	 Nusselder,	
Mackenbach	 &	 Kunst,	 2011).	 Differences	 in	 the	
actual	 life	expectancy	to	age	65	 in	the	US	are	even	
larger	 because	 social	 conditions	 predict	 a	 higher	
likelihood	 of	 premature	 death	 due	 to	 violence	 or	




					What	 is	 missing	 in	 linking	 overarching	
determinants	of	SES	with	health	and	poor	ageing	is	




of	 organic	 parameters.	 For	 example,	 research	 on	
immune	 markers	 in	 the	 Whitehall	 II	 study	 has	
shown	 that	 glucocorticoids	 and	 inflammation	 may	
in	 part	 explain	 how	 the	 body	mediates	 the	 effects	
of	low	SES	thus	leading	to	disease,	and	this	is	partly	
independent	 of	 common	 known	 risk	 factors	
(Stringhini	 et	 al.,	 2013).	 More	 generally,	 recent	
studies	 have	 shown	 that	 SES	 can	 influence	 the	
global	 physiological	 dysregulation	 across	 the	 life	
course,	 measured	 using	 allostatic	 load,	 a	 measure	
of	biological	multisystem	wastage	 (Barboza	Solís	et	
al.,	 2015;	 Merkin,	 Karlamangla,	 Roux,	 Shrager	 &	
Seeman,	2014;).		
					A	 research	 approach	 based	 on	 intermediate	
biomarkers	is	more	powerful	in	identifying	the	links	
between	SES	and	healthy	ageing	than	one	based	on	
traditional	 risk	 factors	 alone	 because	 (a)	 it	 may	
explain	subtle	chronic	effects	acting	throughout	the	
life	 course	 (like	 chronic	 stress)	 that	 are	 not	 easily	
captured	by	questionnaire-based	epidemiology;	 (b)	
it	 allows	 tracing	 signals	 that	 start	 in	 early	 life	
through	to	health	effects	in	later	life;	(c)	it	provides	
an	approach	to	the	discovery	of	new	pathways	and	
causes	 of	 disease,	 particularly	 through	 the	 new	
omic	 technologies	 (Box	 1).	 By	 analysing	
intermediate	 biomarkers	 potentially	 involved	 in	
various	 diseases,	 this	 approach	 is	 likely	 to	 reveal	
some	 common	 (currently	 unknown)	 roots	 of	many	





Omic	 technologies	 allow	 to	 measures	 the	 whole	 set	 of	 compounds	 in	 a	 certain	 compartment	 (e.g.	
proteomics	 is	about	all	proteins).	These	are	 the	definitions	of	 the	omics	available	or	measured	de	novo	 in	
LIFEPATH:	
Epigenomics:	 The	 analysis	 of	 epigenetic	 changes	 in	 DNA,	 histones,	 and	 chromatin	 that	 regulate	 gene	
expression.	Epigenetic	changes	are	changes	other	than	changes	in	DNA	sequence	that	are	involved	in	gene	
silencing.	
Metabolomics:	 The	 scientific	 study	of	 small	molecules	 (metabolites)	 that	 are	 created	 from	chemicals	 that	
originate	 inside	 the	 body	 (endogenously)	 or	 outside	 the	 body	 (exogenously).	 For	 purposes	 of	 the	 present	
report,	 metabolomics	 is	 assumed	 to	 include	 exogenous	 chemicals	 found	 in	 biological	 systems	 in	 their	
unmetabolised	forms.		
Proteomics:	The	analysis	of	 the	proteins	produced	by	cells,	 tissues,	or	organisms.	Analysis	 is	conducted	to	
understand	the	location,	abundance,	and	post-translational	modification	of	proteins	in	a	biological	sample.	






• To	 demonstrate	 that	 healthy	 ageing	 is
highly	 variable	 in	 society,	 due	 to	multiple	
environmental,	 behavioural	 and	 social	
circumstances	 that	 affect	 individual	 life	
trajectories.		
• To	 improve	 the	 understanding	 of	 the
mechanisms	through	which	healthy	ageing	
pathways	diverge	by	social	circumstances,	




by	 individuals	 exposed	 to	 the	 strongest	
adversities,	 by	 using	 an	 experimental	
approach	 (randomised	 experiments	 of	 an	
earned	 income	 tax	 credit	 programme	 in	
New	 York	 and	 Atlanta	 and	 a	 "conditional	




MDRC);	 and	 to	 analyse	 the	 health	
consequences	 of	 the	 current	 economic	
recession	 in	Europe	 (i.e.	 changes	 in	 social	
and	economic	circumstances).		
• To	 provide	 updated,	 relevant	 and




• Europe-wide	 and	 national	 surveys
(updated	to	2014),	including	EU-27;	
• Longitudinal	 cohorts	 (across	 Europe)	with
intense	phenotyping	and	repeat	biological	
samples;	
• Other	 large	 cohorts	 with	 biological
samples	
• A	large	registry	dataset	with	over	a	million
individuals	 and	 very	 detailed	 information	
on	work	trajectories	and	health;	
• A	 randomised	 experiment	 on	 conditional
cash	transfer	for	poverty	reduction	in	New	
York	City.		




					The	 geographic	 location	of	 the	 studies	 is	 shown	
in	 figure	 2.	 	 A	 detailed	 description	 of	 the	 cohorts	
and	corresponding	datasets	 is	presented	 in	Table	1	
(not	 including	 Europe-wide	 national	 surveys).	 Data	
are	 harmonised	 and	 integrated	 to	 conceptualise	
healthy	ageing	as	a	composite	outcome	at	different	
stages	 of	 life,	 resulting	 from	 life-course	
environmental,	 behavioural	 and	 social	
determinants.	
Cohorts	
					LIFEPATH	 includes	 information	 and	 biological	
samples	 from	 eight	 longitudinal	 population-based	
cohorts	 with	 extensive	 phenotyping	 and	 repeat	
biological	 samples,	 nine	 large	 longitudinal	
population-based	 cohorts	 with	 biological	 samples,	
and	a	 very	 large	 cohort	without	biological	 samples	
(WHIP,	 from	 Italy).	 The	 countries	 that	 are	 covered	
by	 the	 cohorts	 are	 France,	 Italy,	 Portugal,	 Ireland,	
UK,	 Finland,	 Switzerland	 and	 Australia.	 These	
cohorts	 are	 only	 a	 small	 proportion	 of	 all	 cohorts	
available	 in	 Europe,	 but	we	 have	 chosen	 them	 for	
the	 combination	 of	 good	 measures	 of	
socioeconomic	 status,	 risk	 factors	 for	 NCD	 and	
biomarkers	 already	 measured	 (or	 availability	 of	
blood	 samples	 for	 further	 testing).	 The	majority	 of	
cohorts	 include	 ‘hard’	 outcomes	 (diabetes,	 cancer,	
cardiovascular	 disease	 -	 CVD,	 total	 mortality),	 and	
the	 extensively	 phenotyped	 cohorts	 also	 include	
several	 measurements	 of	 the	 functional	
components	 of	 healthy	 ageing,	 including	 frailty,	
impaired	vision,	cognitive	 function,	 renal	and	brain	
function,	 osteoporosis,	 sleep	 disturbances	 and	
mental	health.	All	age	groups	are	represented	with	
two	 birth	 cohorts,	 one	 cohort	 of	 adolescents	 and	
several	cohorts	encompassing	young	adults	(age	18	
and	 above).	 Furthermore,	 there	 is	 a	 strong	
representation	of	 elderly	 subjects	 in	 seven	 cohorts	
(Table	 1).	 This	 age	 structure	 allows	 us	 to	 address	
the	 first	 challenge,	 the	 life	 course	 perspective	
(model	described	in	Figure	1).	
Experimental	studies	to	test	policy	strategies	
					Data	 from	 cohorts	 are	 complemented	 by	 data	
from	 the	 evaluation	 of	 two	 randomised	
experiments	 in	 the	 United	 States	 carried	 out	 by	
MDRC	in	New	York:	(a)	the	Opportunity	NYC–Family	
Rewards	 study,	 a	 randomised	 experiment	 of	
conditional	 cash	 transfers	 (CCT)	 to	 help	 families	
break	 the	 cycle	 of	 poverty,	 and	 the	 first	 CCT	
program	 in	 a	 high-income	 country.	 The	 program	
was	 evaluated	 through	 a	 randomised	 controlled	
trial	 involving	 approximately	 4,800	 families	 and	
11,000	 children,	 half	 of	 whom	 could	 receive	 the	
cash	 rewards	 if	 they	 met	 the	 required	 conditions,	
and	half	who	were	assigned	to	a	control	group	that	
could	 not	 receive	 the	 rewards.	 Data	 include	
extensive	 measures	 of	 social	 and	 economic	
conditions	as	well	as	extensive	health	assessments,	
which	 the	 present	 project	 plans	 to	 complement	
with	 additional	 biological	 measures.	 (b)	 The	
Paycheck	 Plus,	 a	 randomised	 experiment	 of	 tax	
credits	 to	 help	 adults	 without	 dependent	 children	
break	the	cycle	of	poverty.	The	Earned	 Income	Tax	
Credit	 is	 a	 federal	 program	 in	 which	 low-income	
individuals	 and	 families	 receive	 an	 annual	 credit	
that	 varies	 according	 to	 their	working	 income.	 The	
program	 was	 evaluated	 through	 a	 randomised	
controlled	 trial	 involving	 approximately	 10,000	
participants,	 with	 control	 participants	 assigned	 to	
the	 current	 maximum	 $500	 annual	 return	 and	
experimental	 participants	 assigned	 to	 a	 maximum	
$2000	 return.	 Data	 include	 extensive	 measures	 of	
social	 and	 economic	 conditions	 and	we	will	 collect	
data	 on	 serum	 cholesterol,	 C-reactive	 protein,	
glycosylated	 haemoglobin,	 blood	 pressure,	
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abdominal	 circumference,	 height,	 and	weight	 after	
the	 intervention.	 	 These	 experimental	 studies	 are	
relevant	to	the	second	challenge,	the	complexity	of	






well	 as	 from	 publicly	 available	 datasets.	 Four	 ‘har	
indicators	 of	 healthy	 ageing	 are	 being	 used	
(incident	 diabetes,	 cancer,	 cardiovascular	 disease,	
and	death),	and	several	functional	and	physiological	
indicators	 are	 also	 available	 (blood	 pressure,	
anthropometry,	 frailty,	 physical	 strength,	 walking	
speed	and	grip	strength,	eye	macular	health,	sleep,	
cognitive	 function	 including	 dementia,	 mental	
health,	 bone	 health,	 renal	 function,	 urinary	
electrolytes	 and	 cardiometabolic	 measures).	 The	
World	Health	Organisation	 increasingly	emphasises	
the	need	 to	 shift	 from	a	definition	of	health	based	
on	 hard	 indicators	 like	 mortality	 and	 diseases,	 to	
ability	and	disability	indicators.	In	addition	to	being	
analysed	 separately,	 in	 LIFEPATH	 these	 measures	
will	 be	 incorporated	 into	 composite	 indicators	 of	
(un)healthy	 ageing.	 The	 contribution	 of	 each	
outcome	 to	 the	 composite	 indicators	 will	 be	
weighted	 based	 on	 the	 severity	 of	 the	 outcome	
(with	premature	death	having	 the	highest	weight).	
To	 achieve	 this,	 we	 will	 incorporate	 methods	 and	
estimates	 from	 other	 projects	 such	 as	 the	 Global	
Burden	of	Diseases	Collaboration	(Lim	et	al.,	2012),	
taking	into	account	life	stages	and	gender.	Because	
the	 GBD	 system	 is	 controversial,	 we	 will	 also	 test	
other	systems	of	weighting	such	as	those	based	on	
mobility,	 impairment	 of	 usual	 activities,	
pain/discomfort	 and	 anxiety/depression	 derived	
from	a	systematic	review	of	the	literature.	Early-life	
health	 events	 (such	 as	 sleep	 disturbances	 and	
changes	 in	 blood	 pressure)	will	 be	 separated	 from	
typically	late-life	problems	like	frailty,	osteoporosis,	
macular	and	cognitive	impairment.				
					In	 LIFEPATH	 we	 have	 operationally	 defined	
healthy	ageing	with	two	components.	First,	through	
a	 general	 statement	 about	 healthy	 ageing	 and	
second,	 through	 recommendations	 about	 variable	
selection	 and	 choice	 of	 analyses	 across	 the	 life	
course	 using	 longitudinal	 datasets;	 these	 are	
provided	below:		
• Statement	 on	 Healthy	 Ageing:	 “Healthy
ageing	 is	 the	 optimal	 state	 of	 performance	









					One	 of	 the	 leading	 hypotheses	 of	 LIFEPATH	 is	
that	 SES	 operates	 partially	 through	 an	 unequal	
distribution	 of	 conventional	 risk	 factors	 for	 poor	
health	 across	 SES	 strata,	 but	 that	 there	 is	 also	 an	
additional	effect	of	SES	on	healthy	ageing	that	is	not	
explained	 by	 these	 conventional	 risk	 factors	 (third	
challenge	 above).	 Therefore,	 having	 good	
information	on	a	number	of	risk	factors	for	disease	
is	 key	 to	 ensure	 the	 success	 of	 the	 project.	 Also,	
crucial	 is	 the	 ability	 to	 encompass	 the	 whole	
trajectory	 that	 links	 SES	 with	 healthy	 ageing	 by	
modelling	 risk	 factors	 (and	 omics,	 see	 below)	with	
proper	 analytic	 tools	 and	 study	 designs.	 These	
include	 mediation	 analysis,	 structural	 equation	





(b)	 the	 relationship	 between	 individual	 risk	 factors	
for	 poor	 health	 and	 their	 combinations	 with	
multiple	 diseases	 and	 (composite)	 indicators	 of	
healthy	ageing;		
(c)	 the	 intermediate	 role	 of	 risk	 factors	 in	 the	




Biological	 embedding	 and	 omic	 biomarkers	
over	the	life	span	
					Differentiating	the	analysis	of	ageing	 in	terms	of	
the	 two	 stages	 of	 build-up	 and	 decline	 allows	 an	
appropriate	 and	 detailed	 exploration	 of	 ageing	
mechanisms,	 and	 the	 use	 of	 iterative	 biological	
measures	 from	 cohorts	 at	 different	 ages.	 For	
example,	 an	 analysis	 of	 the	 first	 ‘build-up’	 stage	








life	 course	 analyses	 is	 central	 in	 LIFEPATH	 and	will	
be	 made	 possible	 by	 the	 integrated	 use	 of	
longitudinal	 cohorts	 capturing	 different	 life	 stages	
with	repeat	measures	and	biological	samples.		
					By	combining	existing	information	from	birth	and	
adult	 longitudinal	 studies,	 LIFEPATH	 is	 organised	
into	 three	 main	 interacting	 streams,	 illustrated	 in	
Figure	3:		
(a) an	 outer	 layer	 of	 the	 project:	 overarching	
DETERMINANTS.	
					The	 focus	 is	 on	 healthy	 ageing	 as	 a	 continuous	
process	 in	 life	 ("life-path")	 and	on	 SES	differentials	
as	 key	 determinants,	 based	 on	 the	 well-
documented	assumption	 that	 SES	over	 time	 is	 one	
of	 the	 strongest	 predictors	 (and	 also	 a	 summary	
measure)	 of	 the	 development	 and	 preservation	 of	
good	 health	 and	 of	 later-life	 diseases	 and	
disabilities;		
(b)	a	middle	layer	of	the	project:	RISK	FACTORS.	
					The	 project	 studies	 the	 influences	 SES	 has	 on	
healthy	ageing	and	 life	expectancy	via	behavioural,	
occupational,	 nutritional,	 environmental	 and	 other	
modifiable	 risk	 factors	 for	 poor	 health,	 from	
childhood	to	adulthood;		
(c)	 an	 inner	 layer	 of	 the	 project:	 BIOLOGICAL	
PATHWAYS	and	human	social	genomics.		
					Omics	 data	 (in	 particular	 epigenomics,	
metabolomics	 and	 transcriptomics),	 is	 already	




This	 will	 allow	 us	 to	 reconstruct	 biologically-
embedded	 life-course	 ageing	 trajectories	 through	
the	integration	of	(i)	early-	and	later-life	SES	and	risk	
factors,	 and	 (ii)	 early-	 and	 later-life	 omic	
measurements	 and	 markers	 of	 inflammation	 or	
immune	response.		
					The	 scheme	 in	 Figure	 3	 explains	 the	 different	
components	and	outcomes	of	the	project,	as	well	as	
the	 types	 of	 biomarkers	 that	 can	 be	 developed	 as	
intermediate	 steps	 between	 socioeconomic	 status	
(SES),	 risk	 factors	 and	 unhealthy	 ageing:	 (a)	
epigenetic	markers,	both	short-term	(and	amenable	
to	 modification),	 and	 long-term	 (irreversible	
changes	that	can	be	attributed	to	early-life	and	late-
life	 exposures);	 (b)	markers	 of	 stress	 and	HPA-axis	
dysregulation;	 (c)	 markers	 of	 inflammation	 and	




will	 be	 measured	 with	 existing	 funds:	 methylome	
(n=4,250);	 inflammation	 markers	 (n=61,000);	
metabolomics	 (n=23,000).	 Most	 cohorts	 have	 C	 -	
reactive	 protein	 (CRP),	 and	 many	 have	 cytokines	
measurements.		
					New	methylome	 analyses	will	 be	 performed	 for	
2,500	 new	 subjects	 and	 new	 transcriptomic	
analyses	for	about	600	subjects.	Peripheral	blood	is	
a	 convenient	 source	 for	 epigenetic	 testing,	 but	
cellular	 heterogeneity	 can	 confound	 or	 mask	 the	
results	(Adalsteinsson	et	al,.	2012;	Consortium	TEP,	
2012;	 Liu	 et	 al.,	 2013),	 because	 epigenetic	
signatures	 differ	 from	 one	 cell	 subtype	 to	 another	
(Reinius	et	al.,	2012).	Moreover,	the	composition	of	
the	 blood	 cells	 can	 change	 under	 a	 plethora	 of	
pathophysiological	 conditions,	 and	 this	 can	also	be	
influenced	 by	 SES.	 The	 importance	 of	 measuring	
epigenetic	 patterns	 across	 specific	 cell	 subtypes	
also	 depends	 on	 disease	 status,	 and	 subtle	
differences	 are	 likely	 more	 important	 for	
multifactorial	 traits.	 For	 these	 reasons,	 the	 first	
analyses	of	the	methylome	will	be	performed	in	two	
specific	blood	cell	types	in	500	Whitehall	II	subjects.	
We	 will	 then	 validate	 the	 findings	 in	 PBMC	 in	
cohorts	 with	 cell	 counts	 available.	 Also,	 the	
biomarker	 stock	will	 be	 enriched	 by	measuring	 IL6	
and	other	 cytokines	 in	 6,600	 additional	 subjects	 in	
Whitehall	II	(funded	by	the	US	NIH)	and	in	Skipogh,	




measure	 the	 relative	 importance	 of	 genetic	
predisposition	 to	 disease	 vs	 environmental	
variables	 including	 SES;	 second,	 we	 can	 look	 at	
gene-environment	 interactions	 with	 our	 non-
genetic	 variables	 including	 SES	 (low-penetrance	
susceptibility);	 third,	 we	 can	 apply	 the	 concept	 of	
Mendelian	 Randomisation,	 i.e.	 identify	 gene	
variants	 that	 are	 associated	 with	 intermediate	
factors	that	connect	SES	with	health	outcomes,	and	
reinforce	 causal	 reasoning	 (given	 that	 no	 genetic	
variants	 have	 been	 clearly	 identified	 that	 directly	
influence	SES		itself).	Genotyping	will	be	performed	
(or	 is	 already	 available)	 through	 other	 funds	 for	
17,000	subjects	from	Airwave,	6,600	from	Whitehall	
II,	 1,100	 from	Skipogh	 and	 6,000	 from	Colaus.	 The	
Cardiometabochip	 (200K	 SNPs)	 will	 be	 used	 (200K	
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statistical	models	 integrating	 the	different	 features	
determining	 healthy	 life	 trajectories.	 Statistical	
models	are	designed	to	(a)	test	different	conceptual	
pathways	 to	 (un)healthy	 ageing,	 integrating	
information	 from	 risk	 factors,	 SES,	 omics	 and	
outcomes	 that	 contribute	 to	 healthy	 ageing;	 (b)	
provide	estimates	of	the	weight	of	different	causes,	
distal/fundamental	 or	 proximal,	 to	 enable	 the	
simulation	 of	 different	 scenarios	 of	 public	 health	
policies	 or	 interventions	 which	 might	 improve	
healthy	living.		
					An	 outline	 of	 the	 different	 aspects	 of	 statistical	
analyses	 is	provided	 in	Table	2.	Statistical	methods	
are	 also	 being	 developed	 to	 investigate	 the	
association	 between	 SES	 and	 healthy	 ageing,	
between	 SES	 and	 risk	 factors,	 and	 between	 risk	
factors	and	healthy	ageing	indices	as	conceptualised	
above.	 Additional	 methodological	 efforts	 will	 rely	
on	 the	 development	 of	 omics	 profiling	 techniques	
integrating	 data	 arising	 from	 different	 platforms,	
and	mechanistic	models	 investigating	 the	 interplay	
of	these	different	sets	of	markers.	
Omic	 signatures	 –	 As	 summarised	 in	 Table	 3,	
numerous	 analyses	 rely	 on	 the	 identification,	 from	
high	 dimensional	 omics	 profiles,	 of	 potential	 omic	
signatures	of	SES-related	exposures/patterns.	
Biological	 mechanisms	 –	 The	 full	 exploration	 of	
biological	mechanisms	 involved	 in	 the	SES-affected	
regulatory	 cascades	 relies	 on	 in-depth	 exploration	
of	 the	 correlation	 structures	 and	 the	 potential	
effect	 mediations	 among	 the	 candidate	 markers	
found	within	and	across	the	different	platforms.	
Time-related	 patterns	 –	 In	 order	 to	 exploit	
longitudinal	 data	 available	 in	 LIFEPATH,	 specific	




holistic	 conceptual	model	 of	 ageing	by	 confronting	
it	 in	an	iterative	way	to	data	from	cohorts	involved	
in	 the	 project.	 This	 model	 will	 integrate	 the	 three	
layers	 (outer:	 determinants;	 intermediate:	 risk	
factors;	 inner:	 biomarkers	 and	 omics),	 so	 that	




is	 present,	 with	 males	 having	 a	 greater	 mortality	
risk	 than	 females.	 Conversely,	women	 have	 longer	
life-expectancies	 but	 live	 with	 higher	 rates	 of	
morbidity	 and	 disability.	 These	 differences	 vary	 in	
their	nature	across	the	lifespan.	Sex	and	gender	are	
central	to	any	research	into	the	processes	of	ageing,	
healthy	 or	 otherwise.	 The	 difficult	 task	 in	
disentangling	 sex	 and	 gender	 has	 been	highlighted	
in	 epidemiology	 by	 Krieger	 (2003)	 who	 advocates	
more	 complex	 formulations	 such	 as	 “biologic	
expressions	 of	 gender”	 and	 “gendered	 expression	
of	biology”.	Here,	we	conceptualise	sex/	gender	“as	
a	 domain	 of	 complex	 phenomena	 that	 are	
simultaneously	 biological	 and	 social,	 rather	 than	 a	
domain	in	which	the	social	and	biological	“overlap””	
(Springer	et	al,	2012).	All	age	groups	are	included	in	
LIFEPATH,	 with	 two	 birth	 cohorts,	 one	 cohort	 in	
adolescents,	 several	 cohorts	 encompassing	 young	
adults	 (age	 18	 and	 above),	 and	 representation	 of	
elderly	subjects	in	seven	cohorts.	
Policy	aims	
					LIFEPATH	 is	 devoted	 to	 develop	 policy	
implications	of	 the	scientific	 findings.	Early	work	 in	
this	 project	will	 develop	 conceptual	models	 of	 the	
intermediate	 mechanisms	 and	 pathways	 through	
which	 SES	 gradients	 influence	 organic	 parameters.	
These	 models	 will	 be	 empirically	 examined	 using	
data	from	the	study	countries	to	produce	evidence	
of	 the	 importance	 of	 different	 pathways	 in	
explaining	 SES	 inequalities	 in	 chronic	 disease	
occurrence.	 The	 LIFEPATH	 project	 takes	 the	
innovative	step	of	combining	these	results	with	the	
existing	 scientific	 and	 policy	 literatures,	 with	 the	
aim	 of	 developing	 a	 health	 impact	 assessment	
framework	(HIA)	which	will	allow	the	research	team	
to	simulate	the	impact	of	different	policy	choices	on	
the	 overall	 occurrence	 of	 disease	 and	 its	
distribution	 across	 different	 SES	 groups.	 A	 number	
of	 HIA	 models	 for	 specific	 disease	 groups	 are	
already	 available.	 These	 will	 be	 further	 developed	
to	capture	healthy	ageing	using	the	results	from	the	
LIFEPATH	 project.	 In	 particular,	 a	 model	 using	
Markov	chains	has	been	developed	by	the	Erasmus	
group	 (DynamoOHIA)	 for	 application	 to	 routine	
data.	 The	 model	 can	 be	 expanded	 and	 enriched	
with	 socioeconomic	 variables	 from	 the	 LIFEPATH	





					We	 describe	 here	 a	 few	 early	 achievements	 of	




					The	 LIFEPATH	 consortium	 brings	 together	 data	
from	 early	 life	 and	 adult	 European	 cohorts	 with	
intense	phenotyping	and	repeat	biological	samples,	
other	 large	 cohorts	 with	 biological	 samples	 and	 a	
large	registry	dataset	with	over	a	million	individuals	
and	very	 rich	 information	on	work	 trajectories	and	
health	 (D’Errico	et	al,	2017).	To	merge	and	analyse	
together	data	from	the	different	LIFEPATH	cohorts,	
information	 on	 occupational	 class,	 education,	
father’s	 occupational	 class	 and	 income	 has	 been	
harmonised.	 The	 harmonisation	 was	 performed	 in	
the	initial	phases	of	the	project	for	each	of	the	early	
life	 cohorts	 and	 adult	 cohorts	 participating	 in	 the	
study	 (Table	 1).	 Detailed	 codebooks	 have	 been	
created	 and	 given	 that	 SES	 indicators	 relevant	 for	
adults	 differ	 from	 those	 important	 to	 characterise	
children	 SES,	 the	 cohorts	 have	 been	 harmonised	
using	different	methods.	
					Amongst	 men,	 the	 proposed	 three-level	
classification	 of	 occupational	 class	 based	 on	 the	
European	 Socio-economic	 Classification	 (ESeC)	 –	
higher,	 intermediate	 and	 lower	 professions	 –	 and	
education	 appear	 not	 to	 differ	 substantially	 from	
more	 detailed	 classifications	 in	 discriminating	
between	 main	 social	 strata,	 and	 in	 predicting	
differences	 in	mortality	 between	 them	 (D’Errico	 et	
al.,	 2017).	 In	 spite	 of	 differences	 in	 recruitment	
among	the	cohorts,	especially	in	terms	of	time,	age,	
gender	 composition	and	 type	of	 sample,	 variability	
in	 the	 distribution	 of	 the	 socioeconomic	 indicators	
in	 the	 different	 study	 populations	 was	 relatively	
low.	 SES	 indicators	 categories	 observed	 in	 the	
different	 cohorts	 were	 also	 roughly	 comparable	 in	
their	distribution	to	those	observed	in	other	studies	
conducted	 in	 Europe,	 including	 several	 conducted	




populations	 did	 not	 share	 the	 same	 characteristics	
of	those	included	in	LIFEPATH.	A	shift	toward	higher	
occupational	 classes	 was	 noted	 between	 fathers’	
and	 subjects’	 occupations	 in	 most	 cohorts,	 which	
seem	 to	 reflect	 an	 increasing	 trend	 of	 social	
improvement	in	these	populations.		
					Strong	differences	 in	mortality	between	genders	
were	 observed	 for	 all	 SES	 indicators,	 with	 much	
higher	 and	 significant	 associations	 in	 males	 than	
females,	 although	 characterised	 by	 variable	
strength	in	the	different	cohorts	(Figure	4).		
SES	as	 a	 risk	 factor	of	physiological	wear	 and	
tear		
					Understanding	 how	 human	 environments	 affect	
our	 health	 by	 ‘getting	 under	 the	 skin’	 and	
penetrating	 the	 cells,	 organs	 and	 physiological	
systems	of	our	bodies	is	a	key	tenet	in	public	health	
research.	 In	 LIFEPATH	 we	 examine	 the	 idea	 that	
early	life	socioeconomic	position	can	be	biologically	
embodied,	potentially	 leading	 to	 the	production	of	
health	 inequalities	 across	 population	 groups.	
Allostatic	load	(AL),	a	composite	measure	of	overall	
physiological	 wear-and-tear,	 could	 allow	 for	 a	
better	 understanding	 of	 the	 potential	 biological	
pathways	 playing	 a	 role	 in	 the	 construction	 of	 the	
social	 gradient	 in	 adult	 health.	 We	 have	
investigated	the	factors	mediating	the	link	between	
two	 components	 of	 parental	 socioeconomic	
position,	 maternal	 education	 (ME)	 and	 parental	
occupation	(PO),	and	AL	at	44	years.	Data	was	used	
from	 7,573	 members	 of	 the	 1958	 British	 birth	
cohort	 follow-up	 to	 age	 44.	 AL	 was	 constructed	
using	14	biomarkers	representing	four	physiological	
systems.	 We	 assessed	 the	 contribution	 of	
financial/materialist,	 psychological/psychosocial,	
educational,	 and	 health	 behaviours/BMI	 pathways	
over	 the	 life	 course,	 in	 mediating	 the	 associations	
between	ME,	PO	and	AL.	ME	and	PO	were	mediated	
by	 three	 pathways:	 educational,	material/financial,	
and	health	behaviours	for	both	men	and	women.	A	
better	 understanding	 of	 embodiment	 processes	
leading	 to	 disease	 development	may	 contribute	 to	
developing	adapted	public	policies	aiming	to	reduce	
health	 inequalities	 (Barboza	 Solís	 et	 al.,	 2016).	 In	
the	 same	 cohort	 we	 also	 showed	 that	 AL	 was	
associated	with	subsequent	health	status.	
SES	as	a	risk	factor	of	high	grade	inflammation	
					To	 explore	 further	 potential	 biological	
embedding	 and	 the	 consequences	 of	
socioeconomic	 position	 experiences	 from	 early	 life	
to	 adulthood,	 we	 investigated	 how	 socioeconomic	
position	indicators	at	different	points	across	the	life	
course	 may	 be	 related	 to	 a	 combination	 of	 28	
inflammation	 markers.	 Using	 blood-derived	
inflammation	 profiles	 measured	 by	 a	 multiplex	
array	 in	 268	 participants	 from	 the	 Italian	
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component	 of	 the	 European	 Prospective	
Investigation	 into	 Cancer	 and	Nutrition	 cohort,	we	
evaluated	the	association	between	early	life,	young	
adulthood	 and	 later	 adulthood	 socioeconomic	
position	 	 with	 each	 inflammatory	 marker	
separately,	 or	 by	 combining	 them	 into	 an	
inflammatory	 score.	 We	 identified	 an	 increased	
inflammatory	 burden	 in	 participants	 whose	 father	
had	 a	 manual	 occupation,	 through	 increased	
plasma	 levels	 of	 CSF3	 (G-CSF;	 β = 0.29;	 P = 0.002),	
and	 an	 increased	 inflammatory	 score	 (β = 1.96;	
P = 0.029).	 Social	 mobility	 was	 subsequently	
modelled	 by	 the	 interaction	 between	 father's	
occupation	 and	 the	 highest	 household	 occupation,	
revealing	 a	 significant	 difference	 between	 ‘stable	
Non-manual’	 profiles	 over	 the	 life	 course	 versus	
‘Manual	 to	 Non-manual’	 profiles	 (β = 2.38,	
P = 0.023).	Low	socioeconomic	position	in	childhood	
is	 associated	 with	 modest	 increase	 in	 adult	
inflammatory	 burden;	 however,	 the	 analysis	 of	
social	 mobility	 suggests	 a	 stronger	 effect	 of	 an	
upward	social	mobility	over	the	life	course.	
Outstanding	issues	
					LIFEPATH	 is	 a	 large	 and	 ambitious	 undertaking,	
and	 it	 will	 try	 to	 address	 some	 of	 the	 main	
challenges	 in	the	field,	but	 it	 is	 foreseen	that	some	
issues	will	remain	outstanding:	
• Measurement	 error	 is	 inherent	 in	 SES	 but
also	 in	 biomarkers	 and	 omics,	 and	 this	 is
likely	 to	 lead	 to	 blurring	 of	 the	 causal
pathways
• In	 spite	 of	 the	 development	 of	 statistical
methods	for	mediation	analysis,	the	complex
(multi-layered)	 nature	 of	 the	 relationships
between	 SES,	 risk	 factors,	 biomarkers	 and
outcomes	makes	 it	unlikely	 that	a	complete
picture	 can	 be	 developed.	 This	 includes	 the
heterogeneity	of	the	cohorts	involved.
• How	 far	 our	 inferences	 can	 be	 extended	 to
other	 populations	 with	 a	 different





contains	 harmonised	 variables	 for	 socioeconomic	
status,	 risk	 factors,	 biomarkers	 and	 outcomes.	
Access	will	be	regulated	by	the	Steering	Committee	
and	 rules	 for	 access	 will	 be	 made	 available	 to	
interested	researchers	via	the	Principal	Investigator.	
Conclusions
The	 marriage	 between	 biology	 and	 social	
sciences		
					Accelerated	 ageing	 and	 many	 human	 diseases	
result	 from	 a	 complex	 interaction	 between	 social	
and	 biological	 factors.	 Risky	 behaviours,	
occupational	 and	 environmental	 exposures	 and	
psychosocial	stress	are	rooted	in	societal	structures,	
have	historical	 foundations,	and	 lead	to	alterations	
in	physiological	 states	 (such	as	 allostatic	 load)	 that	
are	 a	 prelude	 to	 overt	 disease.	 	 The	 study	 of	 the	
interplay	 of	 social	 and	 biological	 factors	 in	
LIFEPATH,	poses	several	challenges:	
Conceptual	 challenges:	 the	 definition	 of	
socioeconomic	 differentials	 depends	 on	 different	
theoretical	constructs	that	put	variable	emphasis	on	
status,	job	position	(social	class),	prestige,	and	other	
factors.	 	 Similar	 challenges	 are	 encountered	 in	
biological	modelling,	 in	relation	to	the	relevance	of	
certain	 markers	 (such	 as	 DNA	 methylation	 or	
metabolomics)	 to	 the	 exploration	 of	 ageing	
trajectories.	
					Practical	 challenges,	 such	 as	 the	 availability	 and	
harmonisation	 of	 good	 and	 well	 measured	
descriptors	 of	 SES	 across	 the	 cohorts.	 The	 same	
challenges	 are	 encountered	 in	 biomarker	 science,	
where	 measurements	 are	 affected	 by	 ‘nuisance	




causal	 relations	 across	 a	 spectrum	 that	
encompasses	 societal	 structures,	 inter-individual	
relationships,	 socioeconomic	 position,	 exposure	 to	
risk	 factors,	 and	 the	underlying	 layers	 of	 biological	
mechanisms	(that	in	turn	involve	whole	individuals,	
tissues,	 cells	 and	 molecules).	 Causal	 models	 have	
been	proposed	 separately	 in	 social	 sciences	 and	 in	
biological	 sciences,	 and	 they	 tend	 to	 be	 very	
different.	 Our	 ambition	 is	 to	 integrate	 them	 not	
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The	 Whitehall	 II	 study	 was	 established	 in	 1985	 to	
examine	 the	 socioeconomic	 gradient	 in	 health	 among	
10,308	London-based	civil	servants	(6,895	men	and	3,413	
women)	 aged	 35–55.	 Baseline	 examination	 (phase	 1)	
took	 place	 during	 1985–1988,	 and	 involved	 a	 clinical	
examination	 and	 a	 self-administered	 questionnaire	
containing	 sections	 on	 demographic	 characteristics,	
























The	 Irish	Longitudinal	Study	on	Ageing	 (TILDA)	 is	a	 large	
prospective	cohort	study	examining	the	social,	economic,	
and	 health	 circumstances	 of	 8,175	 community-dwelling	





Respondents	 completed	 a	 computer-assisted	 personal	
interview	 (n	 =	 8,175)	 and	 a	 separate	 self-completion	
paper	 and	 pencil	 module	 (n	 =	 6,915)	 which	 collected	
information	 that	 was	 considered	 sensitive.	 All	






















nursing	 staff	 (n=5,897).	 A	 total	 of	 5036	 respondents	
completed	 the	 health-centre	 based	 assessment	 and	 a	
further	 861	 respondents	 completed	 a	 home-based	
assessment	 which	 involved	 a	 reduced	 set	 of	 tests.	 	 A	













Generation	 21	 (G	 21)	 comprises	 a	 cohort	 of	 8,647	
newborns	 recruited	 in	 2005–2006	 in	 the	 Porto	
Metropolitan	 Area,	 in	 northern	 Portugal.	 Recruitment	
occurred	 at	 the	 5	 public	 maternity	 units,	 which	 are	
responsible	for	95%	of	all	births	in	the	region	(remaining	
births	occurred	at	private	hospitals)21.	During	the	hospital	
stay,	 women	 delivering	 live	 births	 were	 invited	 to	
participate,	and	92%	of	mothers	agreed.	All	who	agreed	
were	 invited	to	be	re-evaluated	at	child’s	4	years	of	age	

















epidemiological	 occupational	 cohort	 study	 open	 to	 all	
police	 forces	 in	UK.	 	The	 study’s	 current	main	goal	 is	 to	
investigate	 any	 possible	 impacts	 of	 TETRA	 on	 health	 by	
looking	 at	 TETRA	 exposure	 and	 subsequent	 health	
amongst	 police	 officers	 and	 staff.	 The	 study	 was	



























established	with	 the	 initial	 aim	 of	 evaluating	 the	major	
determinants	of	cardiovascular	health.	For	 this	purpose,	
2,485	 (949	 men	 and	 1,536	 women)	 adult	 dwellers	 in	
Porto,	 aged	 18	 years	 or	 over,	 were	 recruited	 between	
1999	and	2003	using	random	digit	dialling.	The	follow-up	
studies	were	 performed	 for	 the	whole	 sample	 in	 2005-
2008,	 and	 in	 2014-2015.	 At	 all	 waves,	 information	 was	
collected	 using	 questionnaires	 administered	 by	 trained	
interviewers,	 self-administered	 questionnaires	 and	
















The	 Swiss	 Kidney	Project	 on	Genes	 in	Hypertension	 is	 a	
longitudinal	 family-based	 study,	 following	 the	
standardised	 EPOGH	 (European	 Project	 on	 Genes	 in	
Hypertension)	 protocol.	 Baseline	 examination	 was	




















in	 blood	 pressure	 regulation	 and	 kidney	 function	 in	 the	
general	 population.	 From	 December	 2009	 to	 March	
2013,	 adult	 participants	 were	 recruited	 in	 two	 regions	
(Berne	 and	 Geneva)	 and	 one	 city	 (Lausanne)	 of	
Switzerland.	 A	 random	 sample	 of	 the	 inhabitants	 was	
drawn	 using	 different	 strategies.	 Inclusion	 criteria	 were	
(1)	 having	 a	 minimum	 age	 of	 18	 years;	 (2)	 being	 of	
European	 ancestry;	 (3)	 having	 ≥one	 and	 ideally	 three	
first-degree	 family	 members	 willing	 to	 participate;	 and	
(4)	 providing	 a	 written	 informed	 consent.	 Pregnant	 or	
breastfeeding	 women	 were	 not	 included.	 The	 general	
participation	 rate	 was	 27.1%.	 At	 baseline,	 we	 collected	
data	on	cardiovascular	and	metabolic	risk	factors	as	well	
as	 on	 the	 prevalence	 of	 kidney	 and	 cardiovascular	
diseases.	During	follow-up,	we	are	collecting	data	on	new	
kidney	and	cardiovascular	events.	The	primary	endpoints	
are	 fatal	 and	non-fatal	 strokes,	 ischaemic	heart	disease,	
heart	 failure	 and	 chronic	 kidney	 disease.	 The	 1,128	








The	 CoLaus	 (COhorte	 LAUSannoise)	 is	 an	 ongoing	
prospective	 study	 assessing	 the	 clinical,	 biological	 and	
genetic	determinants	of	cardiovascular	disease	in	the	city	















included	 6,733	 participants	 aged	 between	 35	 and	 75	
years;	the	first	follow-up	survey	was	conducted	5.5	years	
afterwards	 and	 included	 5,064	 participants.	 In	 each	
survey,	 data	 on	 socio-economic	 status,	 lifestyle,	mental	













Longitudinal	 child	 cohort	 established	 in	 2007/2008.	 The	
study	 takes	 place	 over	 seven	 years	 and	 follows	 the	
progress	of	 two	groups	of	 children:	 1)containing	11,134	
participants	aged	9	months	at	baseline	with	three	study	
waves	(9	months,	3	years	and	5	years)	and	2)	containing	
8,568	 participants	 aged	 9	 years	 at	 baseline	 (9	 years,	 13	
years).	 The	 dataset	 gathered	 contains	 multiple	 SES	

























































SES	 and	 exposure	 variables	
vs	health	outcomes		
Aim:	Harmonise	and	analyse	
different	 indicators	 of	 SES	
available	 in	 the	 cohorts;	
build	 a	 composite	 indicator	
of	 SES;	 analyse	 exposure	
variables.	 Harmonise	 and	
analyse	health	outcomes	and	
build	 indicators	 of	 healthy	
ageing		
Analysis	 of	 all	 cohorts	
yielding	estimates	of:		
-	 Association	 between	 SES	
measures	and	healthy	ageing	
variables		















Aim:	 Identify	 markers	 of	
SES/exposures	 also	 relating	






abilities	 of	 the	 validated	
markers.	 Estimates	 of	 the	
age-related	 susceptibility	
functions,	 and	 identification	
of	 potential	 critical	 age	
ranges	 at	 which	
SES/exposures	are	influential	






disease	 using	 refined	 risk	




a	 SES-based	 score	 for	 the	
prediction	 of	 unhealthy	
ageing.		
Updated	 estimates	 of	 the	
burden	 of	 disease	 for	
selected	exposures.		


























The	 European	 Prospective	 Investigation	 into	 Cancer	 and	




and	Naples	 and	 Ragusa	 in	 southern	 Italy.	 All	 participants	
signed	 an	 informed	 consent	 form	 and	 completed	 two	
questionnaires:	one	about	dietary	habits	(food-frequency)	
and	 one	 about	 lifestyle,	 with	 information	 on	 education,	
socioeconomic	 status,	 occupation,	 history	 of	 previous	
illnesses	 and	 surgery,	 lifetime	 tobacco	 use	 and	 alcohol	
consumption	and	physical	 activity.	 EPIC	database	 records	
were	 linked	 to	 cancer	 and	 regional	 mortality	 registries	
after	 EPIC	 database	 quality	 control.	 All	 EPIC-Italy	 centres	
except	 Naples	 are	 covered	 by	 population-based	 cancer	
registries.	 In	Naples,	 follow-up	 information	was	 collected	
from	 electronic	 hospital	 discharge	 records	 and	 also	 by	
periodic	 personal	 contact	 with	 participants.	 We	 are	













de	 la	 Mutuelle	 Générale	 de	 l’Education	 Nationale)	 is	 a	
prospective	cohort	of	98,995	women	aged	40-65	years	at	
recruitment	 in	 1990	 and	 it	 constitutes	 the	 French	
component	of	EPIC.	The	study	was	established	to	produce	
a	 large	 mass	 of	 data	 relevant	 for	 the	 identification	 of	
environmental	and	molecular	 causes	of	 cancer	and	other	
chronic	diseases,	and	to	contribute	to	the	development	of	
effective	 public	 health	 strategies.	 Data	 on	 residence,	
education,	 early	 life	 events,	 exposures,	 lifestyle	 factors	
and	 life	 events	 were	 collected	 at	 baseline	 and	 follow-up	
questionnaires	were	sent	every	2-3	years	with	more	than	
80%	response.	Mortality	data	were	obtained	by	means	of	




























































The	 GAZEL	 study	 was	 established	 in	 1989	 among	
employees	 of	 the	 French	 national	 gas	 and	 electricity	
company,	 Electricité	 de	 France-Gaz	 de	 France	 (EDF-GDF)	
(Goldberg	 et	 al.,	 2007,	 2015).	 At	 baseline	 (1989),	 20,625	
employees	 (15,011	men	and	5,614	women),	 aged	35–50,	
gave	 consent	 to	 participate.	 The	 study	design	 consists	 of	
an	 annual	 questionnaire	 used	 to	 collect	 data	 on	 health,	





















The	 CONSTANCES	 cohort	 was	 established	 in	 late	 2012	
(Zins	et	al.,	2015).	It	was	designed	as	a	randomly	selected	
representative	 sample	of	 French	adults	 aged	18-69	 years	
at	inception;	200,000	subjects	will	be	included	over	a	five-
year	 period.	 At	 enrolment	 the	 participants	 fill	
questionnaires	 collecting	 data	 on	 health,	 lifestyle,	
individual,	familial,	social	and	occupational	factors,	and	life	
events	 and	 benefits	 from	 a	 comprehensive	 health	
























The	 Melbourne	 Collaborative	 Cohort	 Study	 is	 a	
prospective	 cohort	 study	 of	 41,514	 participants	 (24,469	
women)	 living	 in	 Melbourne,	 Australia.	 Caucasian	
volunteers	aged	between	40	and	69	years	were	recruited	
in	 randomly	 selected	 census	 districts.	 At	 baseline	 (1990–
1994),	 participants	 attended	 clinics	 where	 demographic,	








































The	 Cardiovascular	 Risk	 in	 Young	 Finns	 Study	 (YSF)	
collected	data	on	4,320	children	and	adolescents	aged	3,	
6,	9,	12,	15	and	18	years	at	baseline	who	were	randomly	
chosen	 from	 the	population	 register	 of	 five	 Finnish	 cities	
with	 universities	 with	 medical	 schools	 to	 produce	 a	
representative	sample	of	Finnish	children.	Of	those	invited	










from	the	Social	Security	Administration	archives	 in	 Italy,	covering	almost	8%	of	all	 Italian	workers	employed	 in	 the	private	sector	 in	1985-2010.	Unlike	all	other	
cohorts	in	Table	1	it	does	not	have	biological	samples,	but	it	provides	very	rich	information	on	income,	pensions,	unemployment	benefits,	disability	indemnities,	
workplace	and	job	contracts,	linked	to	hospital	and	mortality	follow-up	(see	box	below).	
sectional	 study	 in	 1980.	 Between	 1980	 and	 1992,	 these	
cohorts	were	 followed	up	at	3-year	 intervals.	The	 follow-
up	 field	 studies	 were	 performed	 for	 the	 whole	 study	
population	 in	 1983	 and	 1986,	 when	 2,991	 (83.2%)	 and	
2,799	 (78.3%)	 subjects	 participated.	 	 In	 1989	 and	 1992	
questionnaires	 were	 sent	 to	 every	 individual,	 but	 only	 a	
subset	 of	 individuals	 had	 their	 height	measured	 in	 these	
survey	 years	 so	 we	 omit	 these	 observations	 from	 the	
analysis.	 In	 2001,	 2,283	 subjects	 (63.5%)	 of	 the	 original	
cohort	 participated	 in	 clinical	 examinations.	 A	 detailed	
description	of	 the	sample	can	be	 found	elsewhere22.	 	For	















level	data	 from	 the	Social	 Security	Administration	archives	
in	Italy,	covering	almost	8%	of	all	Italian	workers	employed	
in	the	private	sector	 in	1985-2010.	Unlike	all	other	cohorts	
in	 LIFEPATH,	 it	 does	 not	 have	 biological	 samples,	 but	 it	
provides	 very	 rich	 information	 on	 income,	 pensions,	
unemployment	 benefits,	 disability	 indemnities,	 workplace	
and	 job	 contracts,	 linked	 to	 hospital	 and	mortality	 follow-
up.	
Mortality	and	hospitalisation	by	
cause	(2001-2012).	
Not	available.	
